Type II Diabetes Policy in California Adolescents
This paper examines California's policy landscape for managing Type II diabetes, with a focus on adolescents and at-risk populations. It reviews three major state initiatives: the mandated provision of diabetes information to seventh-grade students under Education Code Section 49452.7, the Medi-Cal Diabetes Prevention Program (DPP), and regulations requiring insurance coverage for insulin. The paper evaluates the strengths and weaknesses of each policy, proposes appropriate expansions at state and local levels, and identifies special interest groups — including the American Diabetes Association and JDRF — that are instrumental in advancing education, prevention, and intervention efforts. The paper concludes that a collaborative, multi-stakeholder approach is essential to curbing the growing diabetes burden in California.
- Introduction to California's Type II Diabetes Policy Burden: Context for California's rising Type II diabetes burden
- State Policies Addressing Type II Diabetes: Review of three key California diabetes policies
- Appropriate Initiatives at Local and State Levels: Recommended policy expansions at state and local levels
- Special Interest Groups and Advocates for Diabetes Education and Prevention: Roles of advocacy organizations in diabetes policy
- Conclusion: Call for multi-stakeholder collaboration on diabetes
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper systematically evaluates each California policy by identifying both its strengths and its limitations, providing a balanced analytical framework rather than simple description.
- It grounds policy recommendations in cited clinical evidence, such as the DPP's demonstrated 58% reduction in diabetes incidence, lending credibility to its arguments.
- The paper moves logically from existing policy critique to actionable recommendations, connecting state-level strategy to local implementation and stakeholder roles.
Key academic technique demonstrated
The paper demonstrates evidence-based policy analysis: each initiative is described, assessed for effectiveness using empirical data, and then critiqued for gaps in coverage or scope. This technique — describing, evaluating, and recommending — is a standard structure in public health and health policy writing and models how to connect research findings directly to policy implications.
Structure breakdown
The paper opens by establishing the policy context and urgency of Type II diabetes in California. It then reviews three specific state policies in sequence, noting strengths and weaknesses for each. A dedicated section proposes level-appropriate policy expansions (state vs. local). The following section identifies advocacy organizations and details their roles. A brief conclusion synthesizes the need for multi-stakeholder collaboration. This structure — context, critique, recommendation, stakeholders, synthesis — is well-suited to undergraduate health policy writing.
Introduction to California's Type II Diabetes Policy Burden
The burden of Type II diabetes in California has risen to alarming rates. In response, the state government has instituted several policies and initiatives to prevent and treat new-onset or recently diagnosed Type II diabetes. Three major policy areas stand out: the mandatory provision of diabetes information to students, the Medi-Cal Diabetes Prevention Program, and regulations requiring insurance coverage for insulin and diabetes medications.
State Policies Addressing Type II Diabetes
The first of these policies is the provision of Type II diabetes information to the public. Pursuant to the State of California Education Code Section 49452.7, local education agencies have been required since 2010 to provide Type II diabetes information to parents and guardians of incoming seventh-grade students (California Department of Education, 2020). The information, provided in the form of factsheets developed in collaboration with multiple agencies, describes the causes and risk factors of Type II diabetes, available screening tests, and prevention techniques. Unfortunately, limiting distribution to the families of seventh-graders leaves out a large portion of the at-risk population in the state, particularly those living in poverty.
In addition, the state has developed the Diabetes Prevention Program (DPP), an evidence-based lifestyle change program designed to assist Medi-Cal beneficiaries diagnosed with pre-diabetes in preventing or delaying the onset of Type II diabetes (DHCS, 2020). The DPP works by providing information on how to achieve weight loss through trained peer coaches who use a CDC-approved curriculum (DHCS, 2020). Participants who achieve and maintain a minimum weight loss of 5 percent from the first session are eligible to receive ongoing maintenance services after the 12-month core services period (DHCS, 2020). This is designed to help participants sustain healthy lifestyle behaviors. The DPP has been shown to be highly effective: clinical trials indicate that it reduces the incidence of diabetes by 58 percent and delays onset by approximately four years (DPP Research Group, 2009). The primary weakness of the DPP, however, is that it focuses on weight loss only, leaving out other risk factors such as poor diet. For instance, the 2010 National Health and Nutrition Examination Survey showed that approximately 29 percent of Americans with Type II diabetes were not overweight (Bullard et al., 2013). Policies that focus exclusively on weight reduction therefore risk missing this group of patients.
The state has also taken steps to increase access to affordable insulin. One measure is a regulation enacted in 2000 requiring every healthcare service plan — except specialized healthcare plans — to provide coverage for both insulin and non-insulin diabetes treatments. The greatest strength of this initiative is that it helps prevent diabetes-related complications and deaths caused by insulin rationing. However, the policy excludes patients with other forms of diabetes, such as gestational diabetes, and does not address lifestyle change.
Conclusion
In summary, addressing the rising incidence of Type II diabetes in California requires the collaborative effort of multiple stakeholders — including the government, the general public, healthcare professionals, and relevant interest groups. Expanding proven programs such as the DPP, broadening insurance coverage, and engaging advocacy organizations at both state and local levels are essential steps toward reducing the growing burden of this disease.
References
Bullard, K. M., Saydah, S. H., & Imparatore, H. (2013). Secular changes in US prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999–2010. Diabetes Care, 36(8), 2286–2293.
California Department of Education. (2020). Type 2 diabetes information. Retrieved from https://www.cde.ca.gov/ls/he/hn/type2diabetes.asp
DHCS. (2020). Diabetes Prevention Program. Department of Healthcare Services. Retrieved from https://www.dhcs.ca.gov/services/medi-cal/Pages/Diabetes-Prevention-Program.aspx
DPP Research Group. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet, 374(9702), 1677–1686.
Hilliard, M. E., Oser, S. M., Close, K., Liu, N., Hood, K., & Anderson, B. (2015). From individuals to international policy: Achievements and ongoing needs in diabetes advocacy. Current Diabetes Reports, 15(9). doi: 10.1007/s11892-015-0636-z
Create your account
Always verify citation format against your institution’s current style guide requirements.